UnitedHealth Group
UNH
$330.91 -0.77%
Exchange: NYSE | Sector: Healthcare | Industry: Medical Healthcare Plans
Q2 2024
Published: Aug 9, 2024

Earnings Highlights

  • Revenue of $97.86B up 6.6% year-over-year
  • EPS of $4.54 decreased by 22.2% from previous year
  • Gross margin of 21.5%
  • Net income of 4.22B
  • ""We aspire to return to baseline performance in '25 and to grow strongly from there." - Andrew Witty" - Andrew Witty
UNH
UnitedHealth Group Incorporated

Executive Summary

UnitedHealth Group Incorporated (UNH) reported its Q2 2024 financial results elucidating diversified revenue growth amidst a challenging operational landscape, significantly impacted by a recent cyberattack. Total revenues for the quarter reached $97.86 billion, marking a YoY increase of 6.61%, but a marginal QoQ decline of 0.94%. Net income saw a pronounced decline of 22.98% YoY, amounting to $4.22 billion, influenced largely by the financial ramifications of the cyber incident that have introduced unexpected costs. The management remains confident in the strategic positioning for future growth, reinforcing the adjusted EPS guidance for the year of $27.50 to $28.00 despite absorbing $0.60 to $0.70 per share in disruption costs related to the cyberattack. CEO Andrew Witty emphasizes the company’s commitment to expansive growth with significant contributions from core business areas, particularly Optum.

Key Performance Indicators

Revenue
Increasing
97.86B
QoQ: -0.94% | YoY: 6.61%
Gross Profit
Decreasing
21.06B
21.52% margin
QoQ: -4.25% | YoY: -3.27%
Operating Income
Decreasing
7.88B
QoQ: -0.71% | YoY: -2.26%
Net Income
Decreasing
4.22B
QoQ: 399.22% | YoY: -22.98%
EPS
Decreasing
4.58
QoQ: 399.35% | YoY: -22.24%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2024 100,807.00 5.98 +8.1% View
Q3 2024 99,177.00 6.51 +8.6% View
Q2 2024 97,858.00 4.54 +6.6% View
Q1 2024 98,785.00 -1.53 +8.4% View
Q4 2023 93,248.00 5.83 +13.8% View